Form 4 for LRCX Lam Research
Accepted 2023-12-15 00:00:00 ET · period of report 2023-12-14 · accession 0000707549-23-000158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-15 | 2023-12-14 | LRCX | LORD PATRICK J | EVP | M - OptEx | $300.33 | +2,128 | 8,329 | +34% | +$639.1K |
| D | 2023-12-15 | 2023-12-14 | LRCX | LORD PATRICK J | EVP | S - Sale+OE | $750.09 | -2,128 | 6,201 | -26% | -$1.60M |
| D | 2023-12-15 | 2023-12-14 | LRCX | LORD PATRICK J | EVP | M - OptEx | $0.00 | -2,128 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-14 | M | A | 2,128 | $300.33 | 8,329 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2023. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2023-12-14 | S | D | 2,128 | $750.09 | 6,201 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2023. (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.29, inclusive. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-12-14 | M | D | 2,128 | $0.00 | 0 | D | $300.33 · — to 2027-03-02 | 2,128 Common Stock | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2023. (F4) The stock options will become exercisable in three equal installments on 3/2/2021, 03/2/2022, and 3/2/2023. |